Revibe Technologies Announces Clinical Development Updates for its Investigational FokusRx Prescription Digital Therapy for the Treatment of ADHD

/PRNewswire/ -- Revibe technologies, a commercial-stage digital therapeutics company, announced today the positive results of their feasibility study examining...

Related Keywords

United States ,Cambridge ,Cambridgeshire ,United Kingdom ,Peru ,Perou ,Ann Pharmacother ,Lindsay Ayearst ,Margaret Weiss ,Prnewswire Revibe ,Joseph Koziak ,Adolesc Psychopharmacol ,Samd Software ,Medical Device ,Academic Performance Rating Scale ,Revibe Connect ,Executive Dysfunction ,Emotional Dysregulation ,Life Skills ,Social Activities ,Total Score ,School Learning ,Chief Scientific Officer ,Medical Advisory Board ,Clinical Research ,Child Psychiatry ,Cambridge Health Alliance ,Chief Executive Officer ,Mortal Wkly ,Clin Child Adolesc ,Child Adolesc ,Revibe Technologies ,